Literature DB >> 23482841

DNA Methylation Profiles of Protease Nexin 1 (SERPINE2) Gene in Human Cell Lines.

Shan Gao1, Peter A Andreasen.   

Abstract

OBJECTIVE: To investigated whether epigenetic mechanisms contribute to the variable expression of variable protease nexin1(PN-1) encoded by the SERPINE2 gene in different cell types.
METHODS: Working with 5 human cell lines, we determined the CpG methylation status within two CpG islands in the SERPINE2 gene by bisulphate sequencing and the PN-1 mRNA level by Q-RT PCR.
RESULTS: A CpG island spanning the transcription initiation site showed little methylation in 3 of the cell lines and substantial methylation in 2 of the cell lines. A CpG island covering the translation starting site showed full methylation in all investigated cell lines. Methylation within the CpG island was not randomly distributed, but showed accumulation at specific sites. However, we were not able to distinguish any patterns which related the methylation frequency to the gene expression level. Inhibition of CpG methylation with 5-aza-2'-deoxycytidine led to a several fold increase in PN-1 mRNA levels, but based on the results on CpG methylation in the CpG island spanning the transcript, the effect is most likely indirect.
CONCLUSION: We have carefully mapped the CpG methylation pattern in two CpG islands in the 5' part of the SERPINE2 gene without finding any obvious inverse correlation between methylation frequency and expression level.

Entities:  

Keywords:  Cancer; DNA methylation; Protease nexin 1; SERPINE2

Year:  2011        PMID: 23482841      PMCID: PMC3587540          DOI: 10.1007/s11670-011-0092-5

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  46 in total

1.  mRNA expression of matrix metalloproteinases (MMPs) 2 and 9 and tissue inhibitor of matrix metalloproteinases (TIMPs) 1 and 2 in childhood acute lymphoblastic leukemia: potential role of TIMP1 as an adverse prognostic factor.

Authors:  Carlos Alberto Scrideli; Maria Angélica Abdala Cortez; José Andres Yunes; Rosane Gomes de Paula Queiróz; Elvis Terci Valera; Juliana França da Mata; Silvia Regina Caminada Toledo; Priscila Pavoni-Ferreira; Maria Lúcia de Martino Lee; Antonio Sérgio Petrilli; Silvia Regina Brandalise; Luiz Gonzaga Tone
Journal:  Leuk Res       Date:  2009-10-28       Impact factor: 3.156

2.  Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma.

Authors:  B V Kallakury; S Karikehalli; A Haholu; C E Sheehan; N Azumi; J S Ross
Journal:  Clin Cancer Res       Date:  2001-10       Impact factor: 12.531

3.  Decreased methylation and transcription repressor Sp3 up-regulated human monoamine oxidase (MAO) B expression during Caco-2 differentiation.

Authors:  Wai K Wong; Kevin Chen; Jean C Shih
Journal:  J Biol Chem       Date:  2003-07-10       Impact factor: 5.157

4.  Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter.

Authors:  Wei-Guo Zhu; Kanur Srinivasan; Zunyan Dai; Wenrui Duan; Lawrence J Druhan; Haiming Ding; Lisa Yee; Miguel A Villalona-Calero; Christoph Plass; Gregory A Otterson
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

5.  Cell-type-specific repression of the maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cells.

Authors:  Yuji Akiyama; Chihaya Maesawa; Satoshi Ogasawara; Masanori Terashima; Tomoyuki Masuda
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

6.  The myofibroblast is the predominant plasminogen activator inhibitor-1-expressing cell type in human breast carcinomas.

Authors:  Birgitte Vrou Offersen; Boye Schnack Nielsen; Gunilla Høyer-Hansen; Fritz Rank; Stephen Hamilton-Dutoit; Jens Overgaard; Peter A Andreasen
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

7.  SERPINE2 (protease nexin I) promotes extracellular matrix production and local invasion of pancreatic tumors in vivo.

Authors:  Malte Buchholz; Anja Biebl; Albrecht Neesse; Martin Wagner; Takeshi Iwamura; Gerhard Leder; Guido Adler; Thomas M Gress
Journal:  Cancer Res       Date:  2003-08-15       Impact factor: 12.701

Review 8.  The urokinase plasminogen activator system: role in malignancy.

Authors:  Michael J Duffy
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

9.  Disruption of cell-type-specific methylation at the Maspin gene promoter is frequently involved in undifferentiated thyroid cancers.

Authors:  Satoshi Ogasawara; Chihaya Maesawa; Masahide Yamamoto; Yuji Akiyama; Kei Wada; Kentaro Fujisawa; Taro Higuchi; Yuki Tomisawa; Nobuhiro Sato; Shigeatsu Endo; Kazuyoshi Saito; Tomoyuki Masuda
Journal:  Oncogene       Date:  2004-02-05       Impact factor: 9.867

10.  The favorable prognostic impact of tissue inhibitor of matrix metalloproteinases-1 protein overexpression in breast cancer cells.

Authors:  L Nakopoulou; I Giannopoulou; A Ch Lazaris; P Alexandrou; I Tsirmpa; S Markaki; E Panayotopoulou; A Keramopoulos
Journal:  APMIS       Date:  2003-11       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.